KARBE FRANK

CIK 00012767007 companiesFLORHAM PARK, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001276700

Recent Transactions

50 trades

Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2026-05-19+24,122→ 91,622 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2026-01-07−115,000→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Common Stock
2026-01-07−43,125→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Common Stock
2026-01-07$221.50/sh−7,526→ 43,125 total
Tax Payment
Cidara Therapeutics, Inc.$CDTX
Common Stock
2025-12-10$219.60/sh−7,290→ 50,562 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2025-06-03+17,500→ 17,500 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-06-03+10,500→ 67,500 total
Award
Cidara Therapeutics, Inc.$CDTX
Common Stock
2025-02-24+57,500→ 57,500 total
Award
Cidara Therapeutics, Inc.$CDTX
Employee Stock Option (right to buy)
2025-02-24+115,000→ 115,000 total
Purchase
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2024-12-13$7.93/sh+12,500→ 57,000 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2024-05-29$10.16/sh+25,000→ 44,500 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2024-05-23−17,500→ 17,500 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2024-05-23+10,500→ 19,500 total
Award
Better Therapeutics, Inc.
Common Stock
2023-12-18+62,500→ 526,516 total
Purchase
Better Therapeutics, Inc.
Common Stock
2023-07-27$0.73/sh+137,005→ 429,429 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2023-05-25+9,000→ 9,000 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2023-05-25+15,000→ 15,000 total
Purchase
Better Therapeutics, Inc.
Common Stock
2023-04-10$0.82/sh+242,424→ 292,424 total
Purchase
Better Therapeutics, Inc.
Common Stock
2022-09-15$2.09/sh+50,000→ 50,000 total
Award
Better Therapeutics, Inc.
Stock Option (Right to Buy)
2022-07-05+472,200→ 472,200 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2022-05-25+10,000→ 10,000 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2022-04-25+20,000→ 20,000 total
Sale
Myovant Sciences Ltd.
Common Shares
2021-07-07$21.75/sh−3,232→ 212,296 total
Award
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2021-04-15+97,534→ 97,534 total
Award
Myovant Sciences Ltd.
Common Shares
2021-04-15+63,138→ 215,528 total
Sale
Myovant Sciences Ltd.
Common Shares
2021-04-06$18.63/sh−11,080→ 152,390 total
Exercise/Conversion
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2021-02-16−750→ 181,744 total
Sale
Myovant Sciences Ltd.
Common Shares
2021-02-16$21.40/sh−750→ 163,470 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2021-02-16$5.11/sh+750→ 164,220 total
Exercise/Conversion
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2021-01-28−300→ 182,494 total
Sale
Myovant Sciences Ltd.
Common Shares
2021-01-28$24.00/sh−300→ 163,470 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2021-01-28$5.11/sh+300→ 163,770 total
Exercise/Conversion
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2021-01-15−750→ 182,794 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2021-01-15$5.11/sh+750→ 164,220 total
Sale
Myovant Sciences Ltd.
Common Shares
2021-01-15$21.50/sh−750→ 163,470 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2020-12-28$5.11/sh+11,800→ 175,270 total
Exercise/Conversion
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2020-12-28−11,800→ 183,544 total
Sale
Myovant Sciences Ltd.
Common Shares
2020-12-28$30.00/sh−11,800→ 163,470 total
Exercise/Conversion
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2020-12-15−1,050→ 195,344 total
Sale
Myovant Sciences Ltd.
Common Stock
2020-12-15$24.45/sh−670→ 163,470 total
Sale
Myovant Sciences Ltd.
Common Shares
2020-12-15$23.63/sh−380→ 164,140 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2020-12-15$5.11/sh+1,050→ 164,520 total
Exercise/Conversion
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2020-11-30−1,500→ 196,394 total
Sale
Myovant Sciences Ltd.
Common Shares
2020-11-30$24.00/sh−1,500→ 163,470 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2020-11-30$5.11/sh+1,500→ 164,970 total
Exercise/Conversion
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2020-11-17−750→ 197,894 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2020-11-17$5.11/sh+750→ 164,220 total
Sale
Myovant Sciences Ltd.
Common Shares
2020-11-17$20.00/sh−750→ 163,470 total
Sale
Myovant Sciences Ltd.
Common Shares
2020-11-13$20.00/sh−750→ 163,470 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2020-11-13$5.11/sh+750→ 164,220 total

KARBE FRANK

Recent Transactions

Companies

Recent Filings

Address